413PClinical benefits of later line trabectedin and eribulin treatment for soft tissue sarcoma (STS) after pazopanib treatment from the Nishinomiya Sarcoma Cohort Study (NSCS). (25th November 2018) - Narahara, H; Morimoto, M; Tanaka, E; Ueda, S; Yasunaga, Y; Inui, Y; Takahashi, K; Kawata, S